ID   AML14.eos
AC   CVCL_ZC59
SY   Differentiated AML14
DR   Kerafast; EWR003
DR   Wikidata; Q98125472
RX   PubMed=8027673;
CC   Characteristics: Cytokine-induced fully differentiated eosinophilic myelocyte subline of AML14. Proliferates and maintains a differentiated phenotype only if supplemented with CSF2, IL3 and IL5 (Kerafast=EWR003).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8286 ! AML14 [Human leukemia]
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=8027673; DOI=10.1002/jlb.56.1.74;
RA   Paul C.C., Ackerman S.J., Mahrer S., Tolbert M.E., Dvorak A.M.,
RA   Baumann M.A.;
RT   "Cytokine induction of granule protein synthesis in an
RT   eosinophil-inducible human myeloid cell line, AML14.";
RL   J. Leukoc. Biol. 56:74-79(1994).
//